Literature DB >> 26725749

Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration.

O D Konsta1, C Le Dantec2, A Charras2, D Cornec2, E K Kapsogeorgou3, A G Tzioufas3, J O Pers2, Y Renaudineau4.   

Abstract

The pathogenesis of primary Sjögren's syndrome (pSS) is complex, in part due to DNA methylation abnormalities. This study was undertaken to evaluate the importance of global DNA methylation ((5m)C) as determined in minor salivary glands (MSG) from well characterized pSS patients. Twenty-two pSS patients and ten controls were selected, and MSG were stained with anti-(5m)C, anti-(5m)C/anti-cytokeratin (KRT)19, or with anti-SSB/La antibodies (Ab). The DNA methylation status at the SSB gene promoter P1 and P1' was evaluated by methylation-sensitive restriction enzymes (MSRE) coupled with PCR. The effect of the DNA demethylating drug 5 azacytidine (5-Aza) was tested in the human salivary gland (HSG) cell line. In pSS, the reduction of global DNA methylation ((5m)C) was associated with lymphocyte infiltration, the emergence of (5m)C(low) and KRT19(high) acini, and the detection of circulating anti-SSB/La Ab, but not with disease activity (ESSDAI). Next, treating HSG cells with 5-Aza was effective in inducing SSB expression. Finally in pSS patients positive for anti-SSB/La Ab, we further observed DNA demethylation at the SSB gene promoter P1 with consequent SSB overexpression at both the transcriptional and protein levels in salivary gland epithelial cells. In conclusion, our results highlight the importance of DNA methylation in the pathophysiology of pSS and to the emergence of anti-SSB/La Ab.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-SSB antibodies; DNA demethylation; Lymphocytes; Sjögren's syndrome

Mesh:

Substances:

Year:  2015        PMID: 26725749     DOI: 10.1016/j.jaut.2015.12.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  25 in total

Review 1.  JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.

Authors:  Amandine Charras; Pinelopi Arvaniti; Christelle Le Dantec; Marina I Arleevskaya; Kaliopi Zachou; George N Dalekos; Anne Bordon; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

Review 2.  Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.

Authors:  Pilar Brito-Zerón; Soledad Retamozo; Hoda Gheitasi; Manuel Ramos-Casals
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

Review 3.  The Innate Part of the Adaptive Immune System.

Authors:  Sophie Hillion; Marina I Arleevskaya; Patrick Blanco; Anne Bordron; Wesley H Brooks; Jean Yves Cesbron; Srini Kaveri; Eric Vivier; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

4.  Epigenetics: DNA methylation signatures in Sjögren syndrome.

Authors:  Yves Renaudineau; Esteban Ballestar
Journal:  Nat Rev Rheumatol       Date:  2016-09-09       Impact factor: 20.543

5.  Building a Functional Salivary Gland for Cell-Based Therapy: More than Secretory Epithelial Acini.

Authors:  Caitlynn M L Barrows; Danielle Wu; Mary C Farach-Carson; Simon Young
Journal:  Tissue Eng Part A       Date:  2020-09-21       Impact factor: 3.845

Review 6.  Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.

Authors:  Elena Generali; Antonio Costanzo; Carlo Mainetti; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 7.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 8.  The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases.

Authors:  Matteo Vecellio; Haijing Wu; Qianjin Lu; Carlo Selmi
Journal:  Clin Rheumatol       Date:  2020-07-02       Impact factor: 2.980

Review 9.  New insights into the epigenetics of inflammatory rheumatic diseases.

Authors:  Esteban Ballestar; Tianlu Li
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 10.  Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.

Authors:  Laurent Simonin; Elisabeth Pasquier; Christophe Leroyer; Divi Cornec; Julie Lemerle; Boutahar Bendaoud; Sophie Hillion; Jacques-Olivier Pers; Francis Couturaud; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.